• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Using Distributional Cost-Effectiveness Analysis to Improve Equity and Efficiency.

作者信息

Goshua George, Varghese Merilyn, Ito Satoko, Pandya Ankur

机构信息

Section of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine & Yale Cancer Center, New Haven, Connecticut, USA; Center for Outcomes Research and Evaluation, Yale School of Medicine, New Haven, Connecticut, USA.

Section of Cardiovascular Disease, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA; Department of Cardiology, Veterans Affair Connecticut Healthcare System, West Haven, Connecticut, USA.

出版信息

J Am Coll Cardiol. 2025 Apr 1;85(12):1376-1378. doi: 10.1016/j.jacc.2025.01.005.

DOI:10.1016/j.jacc.2025.01.005
PMID:40139895
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12039621/
Abstract
摘要

相似文献

1
Using Distributional Cost-Effectiveness Analysis to Improve Equity and Efficiency.运用分布成本效益分析提升公平性与效率。
J Am Coll Cardiol. 2025 Apr 1;85(12):1376-1378. doi: 10.1016/j.jacc.2025.01.005.
2
The Impact of Tocilizumab Coverage on Health Equity for Inpatients with COVID-19 in the USA: A Distributional Cost-Effectiveness Analysis.托珠单抗纳入医保对美国新冠肺炎住院患者健康公平性的影响：一项分布成本效益分析
Pharmacoeconomics. 2025 Jan;43(1):67-82. doi: 10.1007/s40273-024-01436-1. Epub 2024 Oct 10.
3
Eliciting Trade-Offs Between Equity and Efficiency: A Methodological Scoping Review.权衡公平与效率：方法学范围综述
Value Health. 2023 Jun;26(6):943-952. doi: 10.1016/j.jval.2023.02.006. Epub 2023 Feb 18.
4
Diabetic Retinopathy Screening Among at Risk Populations: Protocol for Distributional Cost-Effectiveness Analysis.高危人群中的糖尿病视网膜病变筛查：分布成本效益分析方案
JMIR Res Protoc. 2025 Apr 30;14:e60488. doi: 10.2196/60488.
5
Strategic Distributional Cost-Effectiveness Analysis for Improving National Cancer Screening Uptake in Cervical Cancer: A Focus on Regional Inequality in South Korea.改善韩国全国宫颈癌筛查参与度的策略性分布成本效益分析：关注区域不平等
Cancer Res Treat. 2018 Jan;50(1):212-221. doi: 10.4143/crt.2016.525. Epub 2017 Mar 30.
6
Modelled Distributional Cost-Effectiveness Analysis of Childhood Obesity Interventions: A Demonstration.基于模型的儿童肥胖干预措施的分布成本效益分析：示范研究。
Appl Health Econ Health Policy. 2023 Jul;21(4):615-625. doi: 10.1007/s40258-023-00813-9. Epub 2023 May 23.
7
Improving health equity and ending the HIV epidemic in the USA: a distributional cost-effectiveness analysis in six cities.改善健康公平，终结美国的艾滋病疫情：六个城市的分配效益成本分析。
Lancet HIV. 2021 Sep;8(9):e581-e590. doi: 10.1016/S2352-3018(21)00147-8. Epub 2021 Aug 6.
8
The Impact of Funding Inpatient Treatments for COVID-19 on Health Equity in the United States: A Distributional Cost-Effectiveness Analysis.《美国为新冠病毒感染者提供住院治疗的资金投入对卫生公平性的影响：一项基于分布的成本效益分析》。
Value Health. 2023 Feb;26(2):216-225. doi: 10.1016/j.jval.2022.08.010. Epub 2022 Oct 1.
9
Distributional Cost-Effectiveness Analysis in Genomic Medicine: Considerations for Addressing Health Equity.基因组医学中的分布成本效益分析：解决健康公平问题的考量因素
Value Health. 2025 May 6. doi: 10.1016/j.jval.2025.04.2162.
10
Aggregate distributional cost-effectiveness analysis: a novel tool for health economic evaluation to inform resource allocation.总体分布成本效益分析：一种用于卫生经济评估以指导资源分配的新工具。
Glob Health Res Policy. 2025 Apr 16;10(1):17. doi: 10.1186/s41256-025-00415-z.

本文引用的文献

1
Health Equity Across the Life Course: A Call to Action for the Cardiovascular Community.贯穿一生的健康公平：心血管领域的行动呼吁。
JACC Adv. 2024 Jul 31;3(7):101125. doi: 10.1016/j.jacadv.2024.101125. eCollection 2024 Jul.
2
Distributional Cost-Effectiveness of Equity-Enhancing Gene Therapy in Sickle Cell Disease in the United States.在美国，增强镰状细胞病公平性的基因疗法的分布成本效益。
Ann Intern Med. 2023 Jun;176(6):779-787. doi: 10.7326/M22-3272. Epub 2023 May 30.
3
The Evolution of the Quintuple Aim: Health Equity, Health Outcomes, and the Economy.五重目标的演变：健康公平、健康结果与经济。
J Am Coll Cardiol. 2021 Nov 30;78(22):2262-2264. doi: 10.1016/j.jacc.2021.10.018.
4
Eliciting the Level of Health Inequality Aversion in England.探究英国对健康不平等的厌恶程度
Health Econ. 2017 Oct;26(10):1328-1334. doi: 10.1002/hec.3430. Epub 2016 Sep 20.
5
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine.《健康与医疗领域成本效益分析的实施、方法学实践和报告推荐：第二版》。
JAMA. 2016 Sep 13;316(10):1093-103. doi: 10.1001/jama.2016.12195.
6
Distributional Cost-Effectiveness Analysis: A Tutorial.分布性成本效益分析：教程
Med Decis Making. 2016 Jan;36(1):8-19. doi: 10.1177/0272989X15583266. Epub 2015 Apr 23.
7
ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines.美国心脏病学会/美国心脏协会关于临床实践指南和绩效指标中成本/价值方法的声明：美国心脏病学会/美国心脏协会绩效指标工作组和实践指南工作组的报告
J Am Coll Cardiol. 2014 Jun 3;63(21):2304-22. doi: 10.1016/j.jacc.2014.03.016. Epub 2014 Mar 27.
8
Recommendations of the Panel on Cost-effectiveness in Health and Medicine.健康与医学成本效益小组的建议
JAMA. 1996 Oct 16;276(15):1253-8.